UBA1 and proximal spinal muscular atrophy: AAV9-mediated delivery of UBA1 was safe and well tolerated in control mice, with restoration of UBA1 levels in SMA mice leading to improvements in all neuromuscular and systemic disease parameters investigated and was also sufficient to correct molecular defects in ubiquitin homeostasis.